...
首页> 外文期刊>Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract >Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas.
【24h】

Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas.

机译:胰腺恶性或浸润性导管内乳头状粘液性肿瘤的预测因素。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this study was to identify useful preoperative diagnostic findings indicative of malignant or invasive intraductal papillary-mucinous neoplasms (IPMN) of the pancreas to determine an optimal operative procedure for IPMN. Sixty-two IPMNs, which consisted of 29 adenomas, 10 borderline tumors, 11 adenocarcinomas in situ, and invasive adenocarcinomas were reviewed from 1990 to 2003. Preoperative predictive factors of malignant or invasive IPMN were analyzed among 10 factors by univariate and multivariate analysis. Diameter of the main pancreatic duct (>==6 mm) and cytological examination of the pancreatic juice (the presence of malignant cells) were identified as independent predictive factors of malignant IPMN, and only cytological examination of the pancreatic juice (the presence of malignant cells) was identified as an independent predictor of invasive IPMN by multivariate analysis (P < 0.05). There was no recurrent disease in patients with adenoma and adenocarcinoma in situ, whereas recurrences occurred in 6 of 12 patients with invasive IPMN. Patient survival in noninvasive IPMN was significantly (P = 0.018) better than that in invasive IPMN (The overall 5-year survival rates were 87.2% and 49.2%, respectively). These results might be useful for selecting an optimal surgical procedure for IPMN.
机译:这项研究的目的是确定指示胰腺恶性或浸润性导管内乳头状粘液性肿瘤(IPMN)的有用的术前诊断结果,以确定IPMN的最佳手术程序。从1990年至2003年,回顾了62例IPMN,包括29例腺瘤,10例交界性肿瘤,11例原位腺癌和浸润性腺癌。术前对10例恶性或浸润性IPMN的预测因素进行了单因素和多因素分析。主胰管直径(> == 6 mm)和胰腺液的细胞学检查(恶性细胞的存在)被确定为恶性IPMN的独立预测因素,仅胰腺液的细胞学检查(恶性的存在)细胞的多变量分析将其确定为浸润性IPMN的独立预测因子(P <0.05)。腺瘤和原位腺癌患者没有复发性疾病,而侵袭性IPMN患者中有6例复发。无创IPMN的患者生存率明显高于有创IPMN(P = 0.018)(5年总生存率分别为87.2%和49.2%)。这些结果对于选择IPMN的最佳手术程序可能有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号